XTX Topco Ltd Sells 4,793 Shares of Maximus, Inc. (NYSE:MMS)

XTX Topco Ltd trimmed its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 40.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,086 shares of the health services provider's stock after selling 4,793 shares during the period. XTX Topco Ltd's holdings in Maximus were worth $529,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank acquired a new stake in shares of Maximus in the fourth quarter worth $29,000. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd acquired a new position in shares of Maximus during the fourth quarter worth approximately $54,000. Finally, IFP Advisors Inc grew its position in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Price Performance

NYSE:MMS traded down $0.53 during mid-day trading on Friday, reaching $68.27. 47,863 shares of the company were exchanged, compared to its average volume of 549,806. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a fifty day moving average of $67.66 and a 200 day moving average of $74.77. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The stock has a market cap of $3.86 billion, a PE ratio of 14.67 and a beta of 0.68.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.76%. Maximus's payout ratio is presently 25.81%.

Insider Activity at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

MMS has been the subject of a number of recent research reports. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a report on Thursday, January 2nd.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.